在急性心力衰竭患者中的拥堵"流行病"
Daniela Mocan1, Radu Ioan Lala1,2, Maria Puschita1
1Multidisciplinary Doctoral School, Vasile Goldis Western University of Arad, 310025 Arad, Romania.
Biomedicines
|May 25, 2024
概括
拥堵是急性心力衰竭 (AHF) 的关键标志,也是住院的主要原因. 了解拥堵表型和改进脱拥堵策略对于更好的患者结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 临床科学 临床科学
背景情况:
- 拥堵是急性心力衰竭 (AHF) 住院,再住院和死亡率的主要驱动因素.
- 拥堵在急性情况下呈现出多种现象,包括体积过载,体积再分配或两者兼而有之.
- 在AHF患者中实现完全的脱血是很困难的,超过一半的患者在出院时经历了残留拥堵.
研究的目的:
- 提高对AHF患者的拥堵现象的理解.
- 探索导致拥堵的病理生理机制.
- 审查新的诊断和管理工具,以有效地减少拥堵.
主要方法:
- 文献综述专注于急性心力衰竭的拥堵.
- 对拥堵的病理生理机制的分析.
- 评估当前和新兴的诊断和管理策略.
主要成果:
- 出院后的残留拥堵是不良心血管事件和不良结果的重要预测因素.
- 不同的拥堵现象需要量身定制的治疗方法来有效地缓解拥堵.
- 新兴工具为改善交通拥堵的诊断和管理提供了潜力.
结论:
- 识别和解决拥堵表型对于优化AHF治疗至关重要.
- 有效的解堵策略对于减少AHF的再住院和死亡率至关重要.
- 需要对先进的诊断和管理工具进行进一步的研究,以提高排挤效率.
更多相关视频
相关概念视频
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Acute Respiratory Failure-II
210
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
210
Acute Respiratory Failure-III
178
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
178
Acute Respiratory Failure-I
198
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
198
Acute Respiratory Failure-V
132
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
132


